THE OUTCOME OF PATIENTS WITH THYROID-CARCINOMA AND GRAVES-DISEASE

被引:41
作者
KASUGA, Y
SUGENOYA, A
KOBAYASHI, S
MASUDA, H
IIDA, F
机构
[1] The Department of Surgery, Shinshu University School of Medicine, Matsumoto, 390
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1993年 / 23卷 / 01期
关键词
THYROID CARCINOMA; GRAVES DISEASE; THYROID STIMULATING ANTIBODY (TSAB);
D O I
10.1007/BF00308993
中图分类号
R61 [外科手术学];
学科分类号
摘要
A total 847 consecutive patients with Graves' disease who underwent thyroidectomy between 1965 and 1990 were found to have a 4.3% incidence of coincident carcinoma of the thyroid. In 68.2% of these cases the tumors were less than 1 cm in diameter and were detected in only 7 patients (19.4%) prior to surgery. Dissection of the regional lymph nodes was necessary in only 11 patients. A review of the patients in 1990 revealed no carcinoma-related deaths with metastases occurring most commonly in the patients with larger tumors and in those whose cancer had been detected prior to thyroidectomy. Although the detection of potential tumors occurring with Graves' disease using preoperative echogram may be of interest, our results suggest that occult micro-carcinoma occurring coincidentally with Graves' disease is not clinically significant as it did not cause any recurrence in this study. Moreover, there was no evidence to suggest that Graves' disease was associated with the increased or rapid growth of these tumors.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 50 条
[21]   Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study [J].
P. Premoli ;
M. L. Tanda ;
E. Piantanida ;
G. Veronesi ;
D. Gallo ;
E. Masiello ;
S. Rosetti ;
C. Cusini ;
F. Boi ;
J. Bulla ;
R. Rodia ;
S. Mariotti ;
V. Capelli ;
M. Rotondi ;
F. Magri ;
L. Chiovato ;
R. Rocchi ;
M. C. Campopiano ;
R. Elisei ;
P. Vitti ;
F. Barbato ;
T. Pilli ;
M. G. Castagna ;
F. Pacini ;
L. Bartalena .
Journal of Endocrinological Investigation, 2020, 43 :109-116
[22]   Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study [J].
Premoli, P. ;
Tanda, M. L. ;
Piantanida, E. ;
Veronesi, G. ;
Gallo, D. ;
Masiello, E. ;
Rosetti, S. ;
Cusini, C. ;
Boi, F. ;
Bulla, J. ;
Rodia, R. ;
Mariotti, S. ;
Capelli, V. ;
Rotondi, M. ;
Magri, F. ;
Chiovato, L. ;
Rocchi, R. ;
Campopiano, M. C. ;
Elisei, R. ;
Vitti, P. ;
Barbato, F. ;
Pilli, T. ;
Castagna, M. G. ;
Pacini, F. ;
Bartalena, L. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (01) :109-116
[23]   RADIOIODINE THERAPY OF AUTONOMOUSLY FUNCTIONING THYROID-NODULES AND OF GRAVES-DISEASE [J].
GUHLMANN, CA ;
RENDL, J ;
BORNER, W .
NUKLEARMEDIZIN, 1995, 34 (01) :20-23
[24]   SUPPRESSION OF THYROID-CELL GROWTH BY SERUM IGG IN GRAVES-DISEASE [J].
ITOH, M ;
SHIMOMURA, N ;
OKUGAWA, T .
HORMONE AND METABOLIC RESEARCH, 1992, 24 (07) :319-321
[25]   FACTORS AFFECTING THYROID-FUNCTION AFTER THYROIDECTOMY FOR GRAVES-DISEASE [J].
HUANG, CS ;
WANG, M ;
SHUN, CT ;
LIAW, KY .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1995, 94 (07) :423-427
[26]   MULTIPLE FORMS OF THYROID STIMULATING HORMONE RECEPTOR ASSOCIATED WITH GRAVES-DISEASE [J].
HUNT, N ;
WILLEY, KP ;
JAHNER, D ;
IVELL, R ;
NORTHEMANN, W ;
CASTEL, MA ;
LEIDENBERGER, F .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1992, 100 (1-2) :22-27
[27]   SENSITIVITY OF THYROIDS TO ENDOGENOUS THYROTROPIN IN PATIENTS WITH GRAVES-DISEASE [J].
TAMAI, H ;
NAGAI, K ;
UEHATA, S ;
KOMAKI, G ;
KIYOHARA, K ;
MIYAUCHI, A ;
KUMA, K ;
KUMAGAI, LF ;
NAGATAKI, S .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1990, 96 (03) :279-287
[28]   INCREASED SERUM NEOPTERIN LEVELS IN PATIENTS WITH GRAVES-DISEASE [J].
WAGNER, R ;
HAYATGHEBI, S ;
ROSENKRANZ, M ;
REINWEIN, D .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1993, 101 (04) :249-254
[29]   SPORADIC MEDULLARY THYROID CARCINOMA IN GRAVES' DISEASE [J].
Semeniene, K. ;
Dauksa, A. ;
Makstiene, J. ;
Sarauskas, V. ;
Velickiene, D. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (03) :368-374
[30]   Thyroid remnant radioiodine ablation in a case of concurrent thyroid carcinoma, graves' disease, and thyroid ophthalmopathy [J].
Mansberg, Robert .
CLINICAL NUCLEAR MEDICINE, 2007, 32 (07) :513-515